New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
10:01 EDTNCS, QUNR, RESI, AMBA, DSGX, PETX, HCLP, OIIM, NGHC, RXDX, TMUS, ADNC, CECE, ABMD, CLVSOn The Fly: Analyst Initiation Summary
Abiomed (ABMD) initiated with an Outperform at Leerink... CECO Environmental (CECE) initiated with a Hold at Jefferies... Clovis (CLVS) initiated with a Neutral at Goldman... Descartes Systems (DSGX) initiated with an Outperform at Raymond James... NCI Building Systems (NCS) initiated with an Outperform at Credit Suisse... National General (NGHC) initiated with an Outperform at FBR Capital... Ambarella (AMBA) initiated with a Buy at Topeka... Audience (ADNC) initiated with a Buy at Topeka... O2Micro (OIIM) initiated with an Outperform at Northland Securities... Altisource Residential (RESI) initiated with a Buy at Compass Point... T-Mobile (TMUS) initiated with an Equal Weight at Evercore... Qunar (QUNR) initiated with a Neutral at Macquarie... Hi-Crush Partners (HCLP) initiated with a Buy at Ladenburg... Ignyta (RXDX) initiated with a Buy at Ladenburg... Aratana Therapeutics (PETX) initiated with a Buy at Jefferies.
News For ABMD;CECE;CLVS;DSGX;NCS;NGHC;AMBA;ADNC;OIIM;RESI;TMUS;HCLP;QUNR;RXDX;PETX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 27, 2015
16:01 EDTABMDAbiomed receives FDA HDE approval for Impella RP System
Subscribe for More Information
January 26, 2015
15:19 EDTABMDAbiomed moves Q3 earnings release to January 28
Subscribe for More Information
13:10 EDTCLVSOppenheimer reports 5.23% passive stake in Clovis
10:47 EDTNGHCNational General acquires Healthcare Solutions Team for upfront payment of $15M
Subscribe for More Information
07:17 EDTABMDSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
06:31 EDTTMUSCablevision to launch cheap mobile phone service, NY Times says
Cablevision (CVC) intends to unveil later today a cheap, Wi-Fi based mobile phone service, according to The New York Times. The first service of its kind to be introduced by a cable company, the offering will include unlimited data, talking and texting worldwide for $29.95 a month, or $9.95 a month for Cablevisionís Optimum Online customers, the newspaper stated. Incumbent wireless carriers include Verizon (VZ), AT&T (T), T-Mobile (TMUS), and Sprint ()S). Reference Link
January 23, 2015
15:34 EDTPETXAratana Therapeutics management to meet with Leerink
Group luncheon to be held on Boston at 12 pm on January 26 hosted by Leerink.
09:04 EDTTMUSSprint guarantees T-Mobile customers $200 minimum trade in value for smartphones
Subscribe for More Information
08:37 EDTHCLPBofA/Merrill U.S. oil & gas analysts to hold an analyst/industry conference call
Subscribe for More Information
January 22, 2015
19:40 EDTTMUSGoogle's entrance into telecommunications may not be beneficial, Re/code says
Subscribe for More Information
11:04 EDTPETXAdvaxis announces FDA acceptance of IND application to conduct Phase 1 trial
Advaxis (ADXS) announced that the U.S. FDA has cleared its Investigational New Drug application to conduct a Phase 1 clinical study of ADXS-HER2 for the treatment of patients with metastatic HER2 expressing solid tumors. The clinical trial, which will be the first-in-human study of Advaxis's lead Lm-LLO immunotherapy product for HER2 expressing cancers, is expected to begin patient enrollment in the first half of 2015. In May 2014, Advaxis was granted orphan drug designation by the FDA for ADXS-HER2 in osteosarcoma.The Phase 1 clinical study is designed to evaluate the safety and tolerability of ADXS-HER2 as a monotherapy in patients with metastatic HER2 expressing solid tumors such as breast, gastric, esophageal, and osteosarcoma. Results from the study will be used to determine the future clinical development program of ADXS-HER2. The safety and efficacy of ADXS-HER2 is currently being evaluated in an ongoing Phase 1/2 veterinary clinical study in pet dogs with osteosarcoma, conducted by Nicola Mason, BVet.Med, Ph.D., DACVIM, of the University of Pennsylvania School of Veterinary Medicine. To date, dogs treated with ADXS-HER2 immunotherapy, after receiving standard of care had a statistically significant overall survival benefit compared to dogs that only received standard of care. Additionally, the preliminary data suggests immune responses induced by ADXS-HER2 targeted pulmonary micrometastases and prevent the development of metastatic disease in the dog's lungs.Advaxis has granted exclusive worldwide rights to Aratana Therapeutics (PETX) to develop and commercialize ADXS-HER2 for the treatment of osteosarcoma in dogs. In July 2014, Aratana filed a U.S. Department of Agriculture product license application for ADXS-HER2 for the treatment of canine osteosarcoma and other cancers. While the USDA has no specific obligation to respond within a prescribed timeframe, the companies expect a response within 12 to 18 months from the date the application was filed.
10:10 EDTTMUST-Mobile introduces 'Smartphone Equality' program
Subscribe for More Information
10:07 EDTTMUST-Mobile CEO teases announcement impacting 'huge number' of subscribers
Subscribe for More Information
January 21, 2015
16:28 EDTTMUSGoogle to launch phone service with Sprint, T-Mobile, The Information says
Google (GOOG, GOOGL) is expected to reach deals to buy wholesale access to Sprint (S) and T-Mobileís (TMUS) voice and data networks in order to sell mobile phone plans directly to customers, according to The Information, citing three people with knowledge of the plans. Google, which may put itself into competition with carrier leaders Verizon (VZ) and AT&T (T) with the new service, "seems likely" to launch the offering this year, according to the report. Reference Link
08:48 EDTTMUST-Mobile should be bought ahead of results, says Pacific Crest
Subscribe for More Information
05:56 EDTTMUSVerizon downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
January 20, 2015
07:27 EDTTMUST-Mobile identified as top pick heading into Q4 results at Oppenheimer
Subscribe for More Information
06:24 EDTTMUST-Mobile warns of unsustainable costs against cellphone giants, Re/code says
T-Mobile (TMUS) owner Deutsche Telekom (DTEGY) claims Verizon (VZ) and AT&T's (T) wealth makes true competition difficult, reports Re/code, citing statements made at Germany's DLD conference. Deutsche Telekom CEO Tim Hoettges stated the dominance of AT&T and Verizon allowed them to make huge bids at the latest midband spectrum auction to further their market lead. Hoettges also stated he was "intrigued" by last year's unsuccessful merger talks with Sprint (S), and warned that T-Mobile's $4B-$5B investment requirements per year are unsustainable. Reference Link
06:17 EDTTMUST-Mobile upgraded to Conviction Buy from Buy at Goldman
Subscribe for More Information
January 18, 2015
13:45 EDTTMUSGoogle in talks to acquire mobile-pay platform Softcard, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use